BNTX
BioNTech SE American Depositary Share
Biological Products, (No Diagnostic Substances)
Best Biotech Stocks 2026 →
BioNTech (BNTX) Stock: Buy, Sell, or Hold?
$87.65
+0.44 (+0.50%)
▲
5d:
-3.36%
30d:
-1.53%
90d:
-4.85%
QUANTITATIVE VERDICT
BUY
MODERATE Confidence (95%)
Quality Score
62/100
Position
SLIGHTLY LOW
30-Day Fair Range
$86.64 – $93.26
Position: SLIGHTLY LOW
Forward P/E & Valuation
-18.6x
Next 12M consensus est.
Wall Street Target
$113.50
+29.5% upside
Options IV & Volume
HIGH Vol
HIGH volume confirmation
Support / Resistance
$84.89 / $91.46
Trend: Uptrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
💡 BUY OPPORTUNITY: BNTX shows positive signals but monitor for confirmation. Company currently unprofitable (negative forward earnings). Moderate conviction.
Get Alerted When BNTX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BNTX is currently trading at $87.65, which is considered slightly low relative to its 30-day fair value range of $86.64 to $93.26.
Technical Outlook: Technically, BNTX is in a uptrend. Immediate support is located at $84.89, while resistance sits at $91.46.
Market Sentiment: BNTX scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $113.50 (+29.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, BNTX is in a uptrend. Immediate support is located at $84.89, while resistance sits at $91.46.
Market Sentiment: BNTX scores 68/100 on our bottoming-setup gauge — the chart has corrected and is stabilizing (RSI reset, momentum turning up), historically a favorable entry zone. Wall Street analysts see significant upside, with an average price target of $113.50 (+29.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$86.64 -
$93.26
Company Quality Score
62/100
(BUY)
Volume Confirmation
HIGH
Confidence Score
94.7%
Trading Range & Key Levels
30-Day Trading Range
$86.64 -
$93.26
Current vs Trading Range
SLIGHTLY LOW
Support Level
$84.89
Resistance Level
$91.46
Current Trend
Uptrend
Technical data as of
Nov 11, 2026
Quantitative Signal Breakdown
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (68/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 29.5% below Wall St target ($113.50)
- BULLISH: Bottoming setup score 68/100 — corrected, stabilizing, and turning up
Fundamental Context
Forward P/E (Next Year Est.)
-18.55
Wall Street Target
$113.50
(+29.5%)
Revenue Growth (YoY)
-15.1%
Earnings Growth (YoY)
-43.2%
Profit Margin
-60.9%
Share BNTX Analysis
Share this live BNTX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.Reddit & Retail Trader Sentiment (BNTX)
Bearish
1 Retail Mentions
Reddit / WSB Comments
1
Bearish
Last Tracked
Sep 14, 2026
Daily AI digest
AI Retail Discussion Summary:
Reddit & WallStreetBets discussions on BNTX are bearish (sentiment score +0.00) across 1 tracked comments.
Aggregated from r/wallstreetbets, r/stocks & StockTwits streams.
View All Trending Reddit & WSB Stocks →
Last updated: November 12, 2026 1:11 AM ET
Data refreshes hourly during market hours. Next update: 2:11 AM
Data refreshes hourly during market hours. Next update: 2:11 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BNTX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
BMRN
Biomarin Pharmaceutical … |
STRONG BUY
28 analysts |
$91 | 56 HOLD |
|
AXSM
Axsome Therapeutics Inc |
STRONG BUY
22 analysts |
$266 | 55 HOLD |
|
INCY
Incyte Corporation |
HOLD
28 analysts |
$132 | 52 HOLD |
|
BBIO
BridgeBio Pharma Inc |
STRONG BUY
22 analysts |
$107 | 33 SELL |
|
WVE
Wave Life Sciences Ltd |
STRONG BUY
21 analysts |
$17 | 34 SELL |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BNTX Research Pages
